20 November 2017 | Paris, France

Challenge & Opportunities

Paris, 20 November 2017

Download the presentations below


Gathering experts in neurodegenerative diseases,
this event will foster interactions between researchers, clinicians, biotech/medtech and pharmaceutical companies.

What to Expect ?

Meet researchers and clinicians with cutting edge expertise in Neurodegenerative diseases

Plenary Session

Hear pharmaceutical companies presenting their views and needs


Express your assets and needs in a flash during a pitch session


Create/identify partnership during a matchmaking session

How does it works?

1. Register for the Plenary Session
2. Create a profile, including a short description and a profile photo
3. Bookings for B2B meetings will open 4 weeks prior to the conference

1. Registration
01 August - 5 November

During the registration you can set when you want to be available for meetings. This determines up to how many meetings you can have.

2. Set up a profile
01 August - 5 November

Next up you create a profile that will be visible to other signed up attendees on the event website. This profile describes what you are looking for and can offer to potential partners.

3. Request meetings
20 September - 10 November

On the 20 of September you can start to receive and send meetings requests to attendees you want to meet at the event.

4. Build connections
A few days prior to the event, the exact time and place for your meeting will be scheduled. You will receive an email with your meetings schedule or you can always check it online or via the app.

Venue & Location

Get in Touch

Cité Internationale

17 boulevard Jourdan
75014 Paris


T: +33 1 46 54 71 53
T: +33 1 46 54 93 64

Medicen Paris Region
T: +33 1 79 68 10 96

NeurATRIS is a French research infrastructure conceived to accelerate the translation of discoveries in basic research into medical innovations for the treatment of nervous system diseases.
All together NeurATRIS state-of-the-art technological platforms represent powerful tools to identify and validate efficient biomarkers for early diagnosis and novel targets for treatments aimed at modifying the progression of neuronal degeneration.
NeurATRIS gives access to its world-class preclinical / clinical facilities and cuttingedge equipment to public and private life science actors through a one-stop shop. NeurATRIS added value is to be able to offer all the continuum in translational research and development.
The unique combination of multidisciplinary expertise and state-of-the-art platforms (neuro-imaging, pharmacology, biotherapies, cell and animal models, behavior, etc.) fully dedicated to neuroscience project is unmatched in Europe.

Medicen Paris Region is a competitiveness cluster for innovative health technologies, with national and international scope. With nearly 300 companies, research centers, universities, hospitals and local authorities as members, it aims to position the Paris region as Europe's leading health cluster. It focuses on five strategic areas: biological diagnostics, diagnostic & interventional imaging, regenerative medicine & biomaterials, digital health and translational medicine. In close collaboration with local, regional and national healthcare innovation players, Medicen Paris Region aims to:

  • Foster the emergence, development and funding of certified collaborative projects in the healthcare sector, in order to create economic value and jobs
  • Increase the international development of innovative startups and SMEs
  • Strengthen the attractiveness of the Paris region, which represents more than 50% of life sciences activity in France